Dr Katharina Hartmann, independent consultant in pharmacovigilance and pharmacoepidemiology
DCVMN initiative 6 – support pharmacovigilance projects to enhance vaccine safety monitoring
August 29, 2019
09:00 CET
International
Organisation:
DCVMN
Dr Katharina Hartmann
Independent consultant in pharmacovigilance and pharmacoepidemiology
Katharina is a seasoned pharmacovigilance expert with over 35 years of experience in vaccine safety. She led national and global PV systems at the Swiss Drug Monitoring Center, Crucell, J&J, and Takeda, establishing and integrating major vaccine PV frameworks. Since 2019, she has consulted for DCVMN and CEPI. A long‑time ETH Zurich lecturer and former president of the Swiss pharmaceutical examination board, she has also contributed to CIOMS, Brighton Definitions, and international training and publications.
